XML 26 R16.htm IDEA: XBRL DOCUMENT
v3.24.3

Selected Balance Sheet Information | 9 Months Ended
--- | ---
Sep. 30, 2024
Selected Balance Sheet Information |
Selected Balance Sheet Information | 7. Selected Balance Sheet Information ​ Prepaid expenses and other current assets (in thousands) ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, | ​ | December 31,
​ |  | 2024 |  | 2023
Prepaid manufacturing expenses | ​ | $ | 382 | ​ | $ | 491
Prepaid clinical research organizations | ​ | ​ | 359 | ​ | ​ | 1,119
Prepaid consulting, subscriptions and other expenses | ​ | ​ | 286 | ​ | ​ | 180
VAT receivable | ​ | ​ | 170 | ​ | ​ | 128
Prepaid insurance | ​ | ​ | 95 | ​ | ​ | 496
​ | ​ | ​ | ​ | ​ | ​ | ​
Total | ​ | $ | 1,292 | ​ | $ | 2,414
​ Prepaid clinical research organizations (CROs) expense is classified as a current asset. The Company makes payments to the CROs based on agreed upon terms that include payments in advance of study services. ​ 7. Selected Balance Sheet Information – (continued) ​ Property and equipment, net (in thousands) ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, | ​ | December 31,
​ |  | 2024 |  | 2023
Computers and office equipment | ​ | $ | 715 | ​ | $ | 902
Other property, plant and equipment | ​ | ​ | 421 | ​ | ​ | 417
Leasehold improvements | ​ |  | 94 | ​ |  | 94
Software | ​ |  | 11 | ​ |  | 11
​ | ​ |  | 1,241 | ​ |  | 1,424
Less: accumulated depreciation and amortization | ​ |  | (927) | ​ |  | (1,002)
​ | ​ | ​ | ​ | ​ | ​ | ​
Total | ​ | $ | 314 | ​ | $ | 422
​ Accrued expenses (in thousands) ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, | ​ | December 31,
​ |  | 2024 |  | 2023
Accrued clinical consulting services | ​ | $ | 2,358 | ​ | $ | 1,700
Accrued manufacturing costs | ​ |  | 820 | ​ |  | 843
Accrued vendor payments | ​ | ​ | 576 | ​ | ​ | 452
​ | ​ | ​ | ​ | ​ | ​ | ​
Total | ​ | $ | 3,754 | ​ | $ | 2,995
​ Accrued employee benefits (in thousands) ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, | ​ | December 31,
​ |  | 2024 |  | 2023
Accrued bonus expense | ​ | $ | 982 | ​ | $ | 1,307
Accrued compensation expense | ​ | ​ | 181 | ​ | ​ | 127
Accrued vacation expense | ​ |  | 128 | ​ |  | 83
​ | ​ | ​ | ​ | ​ | ​ | ​
Total | ​ | $ | 1,291 | ​ | $ | 1,517
​

X
- References No definition available. + Details
Name: | tovx_BalanceSheetInformationAbstract
Namespace Prefix: | tovx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration